Prostaxen (Apalutamide INN) 60mg-Erleada
Prostaxen (Apalutamide INN) 60mg, manufactured by Everest Pharmaceuticals Ltd., is a high-quality generic version of Erleada®, a leading oral therapy used for prostate cancer. Apalutamide is an advanced androgen receptor inhibitor (ARI) that blocks cancer-stimulating signals, helping slow disease progression in aggressive prostate cancer.
It is prescribed for men diagnosed with:
-
Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC)
-
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Prostaxen is supplied as 60mg film-coated tablets, 30 tablets per bottle.
How Apalutamide Works
Apalutamide blocks androgen receptor pathways that fuel prostate cancer growth.
It helps by:
-
Preventing androgen receptor activation
-
Inhibiting cancer cell proliferation
-
Reducing tumor progression
-
Extending survival in advanced prostate cancer
This mechanism provides a strong clinical benefit both before and after cancer spreads.
Indications
Prostaxen 60mg is indicated for:
-
Non-metastatic castration-resistant prostate cancer (NM-CRPC)
-
Metastatic castration-sensitive prostate cancer (mCSPC)
Typically used with androgen deprivation therapy (ADT).
Dosage & Administration
-
Standard adult dose: 240 mg once daily (4 tablets of 60mg),
unless otherwise instructed by an oncologist. -
Take with or without food
-
Swallow tablets whole
-
Should be taken at the same time each day
Missed dose: Skip; do NOT double the dose.
Dose reduction may be required for side effects.
Side Effects
Common side effects include:
-
Fatigue
-
Weight loss
-
Joint pain
-
Rash
-
Hypertension
-
Hot flashes
-
Falls & fractures (rare)
Serious but less common:
-
Seizures
-
Thyroid dysfunction
-
Severe hypersensitivity
Seek immediate medical help if severe symptoms occur.
Pregnancy & Lactation
-
Not recommended for women; Apalutamide can cause fetal harm
-
Men must use effective contraception during treatment
-
Not for use in breastfeeding women
Precautions & Warnings
-
Monitor blood pressure regularly
-
Check thyroid function periodically
-
Risk of fractures — bone health assessment recommended
-
Avoid activities that increase seizure risk
-
Use caution in patients with cardiovascular disease
Therapeutic Class
Androgen Receptor Inhibitors (ARI) for advanced prostate cancer.
Storage Conditions
-
Store below 25°C
-
Keep in a cool, dry place
-
Protect from moisture and light
